Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
Condition: Seasonal Allergic Conjunctivitis Interventions: Drug: Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution; Drug: Ketotifen fumarate ophthalmic solution 0.035% (n = 56); Drug: Brimonidine tartrate ophthalmic solution 0.025% (n = 56); Drug: Experimental: Vehicle ophthalmic solution (n = 56) Sponsor: Bausch & Lomb Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials